share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  04/25 06:10
Moomoo AI 已提取核心信息
The United States Securities and Exchange Commission (SEC) has declared that 180 Life Sciences Corp.'s submission has become effective as of April 24, 2024. The submission, identified by accession number 0001213900-24-034613 and file number 333-276796, was categorized under the submission type POS AM. This notice of effectiveness by the SEC marks a significant regulatory milestone for 180 Life Sciences Corp.
The United States Securities and Exchange Commission (SEC) has declared that 180 Life Sciences Corp.'s submission has become effective as of April 24, 2024. The submission, identified by accession number 0001213900-24-034613 and file number 333-276796, was categorized under the submission type POS AM. This notice of effectiveness by the SEC marks a significant regulatory milestone for 180 Life Sciences Corp.
美国证券交易委员会(SEC)已宣布,180 Life Sciences Corp.s 提交的文件已于 2024 年 4 月 24 日生效。该提交的材料以入库号0001213900-24-034613和文件编号333-276796进行识别,归类为提交类型 POS AM。美国证券交易委员会的这份生效通知标志着180 Life Sciences Corp的一个重要的监管里程碑
美国证券交易委员会(SEC)已宣布,180 Life Sciences Corp.s 提交的文件已于 2024 年 4 月 24 日生效。该提交的材料以入库号0001213900-24-034613和文件编号333-276796进行识别,归类为提交类型 POS AM。美国证券交易委员会的这份生效通知标志着180 Life Sciences Corp的一个重要的监管里程碑
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息